Back to Search
Start Over
Antileukemic Effects of the Novel Agent Elesclomol.
- Source :
- Blood; November 2009, Vol. 114 Issue: 22 p2736-2736, 1p
- Publication Year :
- 2009
-
Abstract
- Chow: Synta Pharmaceuticals Inc.: Research Funding. Nagai:Synta Pharmaceuticals Inc.: Employment. He:Synta Pharmaceuticals Inc.: Employment. Blackman:Synta Pharmaceuticals Inc.: Employment, Equity Ownership. Barsoum:Synta Pharmaceuticals Inc.: Employment, Equity Ownership. Vukovic:Synta Pharmaceuticals Inc.: Employment, Equity Ownership. Hedley:Synta Pharmaceuticals Inc.: Research Funding.
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 114
- Issue :
- 22
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs53079585
- Full Text :
- https://doi.org/10.1182/blood.V114.22.2736.2736